https://www.selleckchem.com/pr....oducts/Trichostatin-
les predicted a group of small molecules, including several histone deacetylase inhibitors (HDACIs), menadione, and mibefradil, which could serve as promising therapeutic agents to reverse acquired resistance to CF therapy. Our findings reveal new targets and alternative therapies to overcome the acquired resistance of GC patients to CF treatment. Our findings reveal new targets and alternative therapies to overcome the acquired resistance of GC patients to CF treatment. The chemokine-like factor (CKLF)-like MARVEL transmembrane
Like
Comment
Share
